Navigation Links
ACE, the Accreditation for Cardiovascular Excellence, cited for Improving Quality and Reducing Costs
Date:4/24/2013

Amelia Island, FL (PRWEB) April 24, 2013

At the MedAxiom Spring conference, Dr. David Wohns, Director of Invasive and Interventional Cardiology at Spectrum Health in Grand Rapids, MI, presented "Improving Quality and Managing Cost: Cath Lab Accreditation: From Good to Great," an overview of the outcomes and payback his cardiac cath lab has obtained from the process of ACE accreditation.

Dr. Wohns stated that “The changes required [for cardiac cath labs] to be competitive will involve lean processes, such as real time, complete documentation for appropriate use criteria (AUC), quality data and outcomes.” An impressive data point achieved by Spectrum Health was a substantial increase in AUC PCI appropriateness scores from 2011 to 2012. Dr. Wohns cited the impact of Value Based Purchasing and Public Reporting and emphasized, “This will affect you, your practice, institution and future success.”

The presentation was well-attended with many questions from the audience. Conference attendees were specifically interested in the cost-benefits of ACE accreditation. Dr. Wohns responded; “ACE was an insurance policy for us, we gained the confidence of cost avoidance associated with RAC audits and malpractice claims. Also, had internal resources been utilized [to achieve the same objective], it is likely we would have had similar or greater expense in staff time, without the validation of external expert review and input. Due to ACE expertise, our time frame for major accomplishments was compressed. ACE’s timeline pushed us to be laser focused in the context of multiple potential distractions.”

Dr. Wohns stated that a critical success factor is a broad understanding by hospital, cath lab administration, quality/data analysts and physicians of the value of the accreditation process. He believes that ACE processes improve the quality performance of cardiovascular procedures, emphasize the use of outcome measures, provide the external oversight of peer review and deliver a customized corrective action plan. Dr. Wohns concluded his presentation by stating that the most important change ACE delivered was driving greater collaboration amongst the silos of the quality department, noninvasive imaging and cath lab, resulting in improved, higher quality care for patients.

Visit the ACE website for additional information and to schedule a complimentary one-hour consultation: http://www.cvexcel.org

About Accreditation for Cardiovascular Excellence

ACE, an independent organization sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology Foundation (ACCF), offers independent evaluation and monitoring of facilities that provide cardiovascular care. By reviewing facility and operator performance and comparing clinical decision-making to nationally accepted best practices, ACE peer review and accreditation services plays a critical role in continuous quality improvement programs. Learn more at http://www.cvexcel.org.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10663131.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Baptist Health South: First US Hospital Network to Receive Full Accreditation from ACE
2. Record Attendance at the Accreditation for Cardiovascular Excellence, ACE, Exhibit Booth at ACC.13
3. ACE, the Accreditation for Cardiovascular Excellence, Cited as Effective Program for Restoring Hospital Reputation
4. Beta Testing Opportunity for URAC Clinically Integrated Network Accreditation Program
5. IASLC awarded accreditation as continuing medical education provider
6. AIUM and AUA guideline development leads to practice accreditation for urologic ultrasound
7. NYUCNs Dr. Laura Wagner: Study finds accreditation improves safety culture at nursing homes
8. Demanding physical work associated with an increased risk of cardiovascular disease
9. Mental vulnerability associated with increased risk of cardiovascular disease
10. Survived cancer? Now look out for cardiovascular risks
11. Increased risk of cardiovascular disease for pregnant women with high blood pressure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... NY (PRWEB) , ... January 20, 2017 , ... ... VW+ 001 and its sugar-free alternative VW+ 002. The drinks have been produced ... with optimal conditions to perform during your workout. , After a successful launch ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
(Date:1/20/2017)... ... 2017 , ... “Knowledge is God’s Lighthouse”: a moving and colorful collection ... is the creation of published author, Gene Gaapf, a retired truck driver, and a ... have been writing since high school and have many different titles,” Gaapf mentions about ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... an On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician ... on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... BOSTON , Jan. 19, 2017  Stealth BioTherapeutics ... therapeutics to treat mitochondrial dysfunction, today announced new additions ... , M.D., as Chief Medical Officer, and Daniel ... Stealth announced that Jim Carr , Pharm.D. has ... "We are pleased to welcome Doug and Daniel ...
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: